P
oisoning may result from intentional or unintentional exposures, recreational drug use, and therapeutic use of drugs or other agents. Although mortality and serious morbidity in poisonings are uncommon, patients requiring hospitalization often require intensive care. The appropriate management of poisoned patients should improve outcome and decrease complications. Evidence-based information is minimal in toxicology because the variety of drugs and doses that patients are exposed to limits the ability to conduct clinical trials of specific interventions. Current recommendations for severely poisoned patients are based on limited data from animal and human studies, case reports, pharmacokinetic information, known pathophysiology, and often consensus opinion. Studies in animal models and human volunteers do not replicate clinical situations commonly encountered in patients. Therapeutic guidelines can be suggested but may not be supported by definitive evidence.
The management of a poisoned patient often involves emergency physicians, primary care physicians, and intensivists. Table 1 summarizes some management issues before intensive care unit (ICU) admission (1-7), and additional material can be consulted for more information (8, 9) . This review will focus on interventions likely to be used in the ICU.
GASTROINTESTINAL DECONTAMINATION
Whole bowel irrigation is a technique to prevent absorption of drugs that can be initiated in the emergency department or ICU. Large volumes of a polyethylene glycol electrolyte solution (1-2 L/hr for adults) are administered until the rectal effluent is clear or toxin elimination is confirmed. A nasogastric tube is often necessary to effectively administer the electrolyte solution. The airway must be protected in patients with depressed level of consciousness or respiratory depression. In addition, the head of the bed should be elevated to 45°to decrease the likelihood of vomiting and aspiration. Whole bowel irrigation is contraindicated in patients with ileus, gastrointestinal (GI) obstruction or perforation, hemodynamic instability, or intractable vomiting. This technique has been suggested for enhancing elimination of substances not well adsorbed by activated charcoal such as iron, lithium, sustained-released or enteric-coated medications, and illicit drug packets (8) . Although some volunteer studies show decreased bioavailability of ingested drugs, the impact of whole bowel irrigation on clinical outcomes has not been assessed. Currently, whole bowel irrigation is not indicated for ingestions other than those mentioned here.
ENHANCED ELIMINATION OF TOXINS
Several techniques use hepatic and renal mechanisms to eliminate toxins. Most of these interventions are initiated in the ICU setting. Multiple-dose activated charcoal (MDAC) enhances elimination of drugs by repeated oral administration of activated charcoal. MDAC adsorbs drugs or metabolites that are actively secreted into the bowel following hepatic metabolism. Drugs or metabolites also are adsorbed after active or passive diffusion into the GI tract (GI dialysis). Clinical studies have not established the optimum dosing regimen. Following the initial dose of activated charcoal, subsequent doses of 0.5-1 g/kg every 4 hrs or an infusion via nasogastric tube of Ն12.5 g/hr can be administered (10) . Smaller doses administered more frequently may decrease the incidence of vomiting. Factors that should be assessed before considering this technique include patient cooperation, level of consciousness, gas-tric emptying, and presence of vomiting. Following the initial dose, subsequent doses of activated charcoal should not contain a cathartic because of the potential for persistent diarrhea, dehydration, electrolyte abnormalities, and abdominal discomfort. Evidence that MDAC reduces morbidity or mortality rates in poisoned patients is lacking (11) . Studies suggest that elimination of carbamazepine, dapsone, phenobarbital, quinine, and theophylline is enhanced with MDAC (11, 12) . Use of MDAC for other drug overdoses is not recommended.
Forced diuresis by administration of large volumes of isotonic fluids and diuretics to increase renal excretion of drug or metabolite is of limited clinical value. It is not recommended because of potential volume overload and electrolyte abnormalities. Urinary alkalinization to enhance excretion of weak acids is beneficial only for salicylates and phenobarbital/primidone. Sodium bicarbonate should be administered to achieve a urine pH Ն7.5. Hypokalemia often results and must be corrected to achieve adequate urinary alkalinization.
Invasive techniques such as hemodialysis and hemoperfusion are reserved for elimination of specific life-threatening toxins. Hemodialysis is particularly suited for drugs or metabolites that are water soluble, have a low volume of distribution, have a molecular weight Ͻ500 Da, and have low plasma protein binding. Hemodialysis may be difficult to initiate in the hemodynamically unstable patient. Hemodialysis can be considered for poisonings with methanol, ethylene glycol, salicylates, and lithium. Hemoperfusion involves the passage of blood through an absorptive-containing cartridge (usually charcoal). This technique removes substances that have a high degree of plasma protein binding. Charcoal hemoperfusion may be indicated for intoxications with carbamazepine, phenobarbital, phenytoin, and theophylline. There is limited experience with continuous hemofiltration techniques (arteriovenous and venovenous) as new modalities for drug removal in poisonings (13, 14) . Smaller drugs are transported across a semipermeable membrane in response to hydrostatic pressure gradients. These techniques may be attractive in hemodynamically unstable patients who cannot tolerate hemodialysis or hemoperfusion (15) . Although significant drug clearance has been reported, no data are currently available on the effect of these techniques on clinical outcomes.
SPECIFIC POISONINGS
Acetaminophen. Acetaminophen is one of the most common drugs in overdoses, and knowledge of appropriate management is important to prevent hepatic failure and death. Liver damage can occur with ingestions of 7.5-10 g in adults, but lower doses may be toxic in chronic alcohol users or malnourished individuals with low glutathione reserves (16) . Activated charcoal adsorbs acetaminophen and many coingestants and should be administered (17) . Activated charcoal interferes only slightly with the effectiveness of N-acetylcysteine (NAC), and the NAC dose does not require adjustment. An acetaminophen concentration should be obtained Ն4 hrs after ingestion and compared to the RumackMatthew nomogram to determine the need for NAC therapy. The nomogram is useful only for single acute ingestions. NAC should be administered orally (140 mg/kg loading dose, then 70 mg/kg every 4 hrs for 72 hrs) if the concentration falls above the lower "possible hepatic toxicity" line. NAC therapy is most effective when initiated in the first 8 hrs following ingestion, but it is recommended to be initiated as late as 24 hrs after a significant ingestion (18) . It is reasonable and appropriate to administer NAC Ͼ24 hrs after ingestion if toxic concentrations of acetaminophen are present or hepatic enzymes are elevated (19) . Late administration of NAC has demonstrated beneficial effects on mortality rate in fulminant hepatic failure due to acetaminophen toxicity (20) . No firm guidelines are established for administration of NAC in chronic ingestions or multiple ingestions over time. NAC administration should be strongly considered if hepatic enzymes are elevated at presentation. Antiemetics frequently are required to improve tolerance of oral NAC. An intravenous formulation of NAC is not available in the United States, but the oral preparation has been given intravenously (21, 22, 23) . Shorter courses of therapy with NAC recently have been proposed (24) . The local Poison Control Center should be contacted for assistance with intravenous NAC regimens and short course therapy. Extended-release forms of acetaminophen may result in delayed elevations of acetaminophen concentrations. Concentrations should be determined 4 and 8 -10 hrs after ingestion and NAC initiated if either concentration is possibly toxic (25) .
Alcohols (Ethylene Glycol and Methanol).
Poisonings with ethylene glycol and methanol are infrequent but can result in significant morbidity and mortality rates. Cardiopulmonary and neurologic symptoms include pulmonary edema, hypotension, ataxia, central nervous system depression, seizures, and coma. Nausea, vomiting, and abdominal pain are frequent. Visual disturbances (blurred vision, blindness, optic disc hyperemia) are hallmarks of methanol toxicity, and urinary calcium oxalate crystals may suggest ethylene glycol ingestion. Symptoms may be delayed if ethanol is also consumed. Both ingestions are classically characterized by an anion gap metabolic acidosis and an osmolar gap. However, other patterns of metabolic disturbance may be present (26, 27) . In early presentations, sufficient time may not have elapsed for metabolism to toxic acids (glyoxylic acid, oxalic acid, formic acid), or high concentrations of ethanol may prevent metabolism of other alcohols leading to an osmolar gap without an anion gap metabolic acidosis. Late presentations may not manifest an osmolar gap if the alcohol already has been metabolized to acid metabolites, but an anion gap acidosis will be prominent.
Practice guidelines based on available literature have been proposed for treatment of ethylene glycol and methanol poisonings (28, 29) . Aggressive supportive care is needed in these ingestions. A secure airway must be maintained, and thiamine, folate, and multivitamin supplements usually are indicated. Folinic acid (leucovorin) in a dose of 1 mg/kg up to 50 mg every 4 -6 hrs for 24 hrs is suggested in methanol poisoning to provide the cofactor for formic acid elimination. Hypertonic glucose may be necessary to treat hypoglycemia. Gastric lavage may be considered within 1 hr of ingestion. Although activated charcoal does not adsorb alcohols, administration may be appropriate if other drugs are suspected. Fluids should be administered to maintain adequate urine output especially since ethylene glycol is excreted by the kidneys. Some clinicians recommend aggressive use of bicarbonate, but benefit has not been confirmed.
Two interventions can prevent metabolism of these alcohols to toxic metabolites. Ethanol can be administered orally or intravenously to maintain a blood concentration of 100 -150 mg/dL. Ethanol is preferentially metabolized by alcohol dehydrogenase. Fomepizole (4-methylpyrazole) is an inhibitor of alcohol dehydrogenase that also prevents metabolism to acid metabolites (30, 31) . The potential advantages of fomepizole are the ease of administration (intravenous bolus), the lack of central nervous system depression, and no requirement for monitoring blood concentrations. The high cost is a disadvantage, and cost-effectiveness analyses are lacking. If the alcohol has been completely metabolized to acid, the use of ethanol or fomepizole is unlikely to benefit the patient. Hemodialysis is necessary to remove the alcohol and toxic metabolites. Indications for hemodialysis include significant or refractory acidosis, visual impairment, renal failure, and pulmonary edema. Hemodialysis for elevated concentrations of the specific alcohol often is recommended, but most laboratories are unable to provide concentrations in a timely manner. Hemodialysis is continued until the acidosis is resolved. Hemodialysis may not be necessary in patients without acidosis who are treated with fomepizole, but this approach is controversial and requires further study.
Amphetamines and Related Drugs. Amphetamines, methamphetamines, and related agents increase central and peripheral catecholamine concentrations, which result in a sympathomimetic syndrome. Clinical manifestations often include tachycardia, hyperthermia, agitation, hypertension, and mydriasis. Hallucinations and acute psychosis are also common. The adverse consequences of these drugs include myocardial ischemia, arrhythmias, seizures, intracranial hemorrhage, stroke, rhabdomyolysis, necrotizing vasculitis, and death. A commonly abused drug in this class is 3,4-methylenedioxymethamphetamine, a designer drug associated with rave parties (32) . It is commonly known as ecstasy, XTC, E, or MDMA. It is ingested orally and acts as a stimulant and hallucinogen by stimulating serotonin release and inhibiting serotonin reuptake in the brain. Bruxism and jaw clenching are clues to use of ecstasy. In addition to the previously mentioned complications, hyponatremia and liver injury progressing to fulminant failure have been reported (33, 34) . ICU care for patients with amphetamine intoxication is primarily supportive. Gastric lavage has little role since most drug is absorbed at the time of presentation. A careful clinical assessment should be made for potential complications. Intravenous hydration for possible rhabdomyolysis may be warranted in individuals with known exertional activities, hyperthermia, or evidence of intravascular volume depletion pending creatine kinase results. Benzodiazepines are used for control of agitation, and haloperidol is reserved for patients who do not adequately respond to benzodiazepines.
␤-Blockers. The clinical effects of ␤-blockers vary with lipid solubility, oral availability, metabolism, membranestabilizing activity, and intrinsic sympathomimetic activity (35, 36) . Significant toxicity manifests as bradycardia, atrioventricular or intraventricular block, and/or hypotension. Negative inotropy contributes more to hypotension than rate-related decreases in cardiac output, and bradycardia may not be present in symptomatic patients (37) . Lipid soluble ␤-blockers such as propranolol, metoprolol, acebutolol, and timolol can cause delirium, coma, and seizures. Toxicity usually occurs within the first 6 hrs of ingestion, but delayed toxicity may result from extended-released preparations. The initial treatment of bradycardia and hypotension usually consists of atropine and isotonic fluids. However, the response to atropine is frequently inadequate, and additional therapy usually is warranted. Despite variable success rates, glucagon is considered to be the antidote for ␤-blocker toxicity because it increases cyclic adenosine monophosphate concentrations intracellularly resulting in inotropic and chronotropic effects (38) . The initial dose is 2-5 mg intravenously followed by a dose of 10 mg if needed. The goal of treatment is improvement in blood pressure and perfusion rather than an increase in heart rate. For responsive patients, a continuous infusion can be initiated at 2-10 mg/hr. Adverse effects of glucagon include nausea, vomiting, hyperglycemia, and hypocalcemia. There are reports of benefit of calcium chloride (1 g of 10% solution) in this setting (39, 40) . Ventricular pacing (transthoracic or transvenous) may be considered in refractory cases if bradycardia is assessed to significantly contribute to hypotension. Adrenergic drugs such as dobutamine, dopamine, norepinephrine, and epinephrine are often ineffective at usual doses, but some patients respond to higher doses. Phosphodiesterase inhibitors such as milrinone, intra-aortic balloon pump, and cardiopulmonary bypass may be considered as salvage therapy for refractory cases. Recently, high-dose insulin infusions together with glucose to maintain euglycemia have been shown to promote recovery in an animal model (41) . Insulin has been postulated to improve inotropy by increasing carbohydrate uptake in myocytes or increasing cytoplasmic calcium concentrations.
Calcium Channel Blockers. Calcium channel blockers produce varying degrees of negative inotropy, vasodilation, bradycardia, and atrioventricular conduction block. Verapamil is most commonly associated with serious morbidity and mortality (42) . Toxic manifestations include bradycardia, hypotension, and, less commonly, central nervous system findings such as lethargy, confusion, and coma. Calcium chloride (10-mL intravenous bolus of a 10% solution) should be administered as the initial intervention provided that digoxin toxicity has been excluded. A continuous infusion of calcium chloride (20 -50 mg·kg Ϫ1 ·hr Ϫ1 ) is required to sustain increases in blood pressure. Ionized calcium concentrations should be assessed regularly (43) . In patients unresponsive to calcium, glucagon has been reported to be beneficial (44, 45) . Vasopressors, often in high doses, may reverse refractory vasodilation, and ventricular pacing may be necessary. Insulin-glucose infusions are reported to be beneficial, but the optimum doses are not defined (insulin 0.1-10 units·kg Ϫ1 ·hr Ϫ1 , glucose 10 -75 g/hr) (46) . Intra-aortic balloon pump or cardiopulmonary bypass can be considered for hypotensive patients unresponsive to other interventions (47) .
Carbon Monoxide (CO). CO poisoning is a common cause of morbidity and mortality in the United States (48) . Due to its affinity for hemoglobin, CO toxicity results in impaired transport and release of oxygen causing cellular hypoxia and possibly direct damage at the cellular level. Cellular hypoxia can result in altered mental status, angina, arrhythmias, and seizures. Diagnosis requires a high level of suspicion. Pulse oximetry inaccurately reflects oxygen saturation because it cannot distinguish carboxyhemoglobin from oxyhemoglobin (49) . Venous or arterial carboxyhemoglobin concentrations should be measured by spectrophotometer and interpreted carefully. Carboxyhemoglobin concentrations as high as 10% may occur in smokers and in urban areas. In addition, a normal carboxyhemoglobin concentration may not reflect prior exposure of the patient. High-flow oxygen by nonrebreather mask or intubation with administration of 100% oxygen should be initiated as soon as possible while confirmatory tests are obtained. An electrocardiogram, chest radiograph, and arterial blood gas measurement should be obtained to assess severity of exposure. A metabolic acidosis implies significant exposure with tissue hypoxia. Hyperbaric oxygen therapy shortens the half-life of carboxyhemoglobin to 15-30 mins compared with 40 -80 mins with 100% oxygen. The indication for and benefits of use of hyperbaric oxygen in CO poisoning continue to be debated (50, 51) . Table 2 lists indications that have been proposed. A recent clinical trial suggests that hyperbaric oxygen decreases the incidence of postexposure cognitive deficits (52) .
Cocaine. Cocaine use can result in a typical sympathomimetic syndrome with findings of tachycardia, dilated pupils, hypertension, hyperthermia, and agitation. Benzodiazepines are used liberally for control of agitation. Haloperidol is reserved for overt psychosis in patients who are unresponsive to benzodiazepines. Cardiovascular complications include hypertension, arrhythmias (ventricular or supraventricular), myocardial ischemia, and rarely aortic dissection (53) . Chest pain thought to be ischemic usually responds to nitroglycerin and/or benzodiazepines (54, 55) . Aspirin should be administered due to increased platelet aggregation and possible thrombosis (56) . Phentolamine, an ␣-adrenergic antagonist that may affect vasoconstriction, is considered a second-line agent for chest pain (57) . Thrombolysis for myocardial infarction may be considered when other interventions have failed and invasive reperfusion options are not available. Severe sustained hypertension may be treated with labetalol or other vasodilators such as nitroprusside. Neurovascular complications include seizures, cerebral infarction, intracranial hemorrhage (intracerebral, intraventricular, subarachnoid), and rarely cerebral vasculitis (58) . Patients with subarachnoid hemorrhage should be evaluated for underlying vascular lesions amenable to surgery. Seizures respond best to benzodiazepines and not to phenytoin. Other supportive care is based on the underlying lesion. Pulmonary complications of cocaine are less frequent and include barotrauma, noncardiogenic pulmonary edema, bronchospasm, interstitial pneumonitis, and alveolar hemorrhage (59) . Hyperthermia and rhabdomyolysis can occur and are exacerbated by environmental hyperthermia. It is reasonable to institute vigorous hydration to increase urine output pending results of creatine kinase values. Bowel ischemia has been described and may require surgical intervention.
Cyclic Antidepressants. Antidepressants are responsible for the third largest number of deaths from overdose in the United States, with the majority due to cyclic antidepressants (60) . Principle toxicities include depressed level of consciousness, wide complex arrhythmias, seizures, and hypotension. Anticholinergic effects include mydriasis, fever, dry skin, delirium, tachycardia, ileus, and urinary retention. Life-threatening complications usually occur within 6 hrs of ingestion. Serum alkalinization and sodium loading with sodium bicarbonate should be instituted for a prolonged QRS and wide complex arrhythmias (61) . However, the exact threshold for instituting therapy based on QRS duration has not been definitively established. Proposals have included a QRS Ͼ0.10 secs or Ͼ0.16 secs and an R wave in AVR Ն3 mm (62, 63) . A QRS that is prolonging over time also should prompt consideration of therapy. Bicarbonate is administered in 50 -100 mEq boluses (1-2 mEq/kg) to alkalinize the blood pH to 7.45-7.55. Hyperventilation to achieve alkalinization may be less effective but useful in patients who do not tolerate the sodium and volume load (64) . The optimum pH is probably best determined by clinical end points such as narrowing of the QRS or reversal of arrhythmia. Following bolus administration of sodium bicarbonate, continuous infusion can be maintained for 4 -6 hrs and tapered. Hypertonic saline also has been reported to be effective Lithium. Lithium has a narrow therapeutic index, and toxicity may occur with acute, acute on chronic, or chronic ingestions. The significance of a lithium concentration must be considered in conjunction with clinical findings because of variability in development of toxicity. Chronic ingesters of lithium have a high total body lithium burden that results in toxicity at lower serum concentrations. In acute ingestions, GI symptoms may occur early with central nervous system symptoms developing later after tissue distribution. In chronic ingestions, neurologic abnormalities are the major manifestations and include tremor, clonus, agitation, lethargy, dysarthria, delirium, seizures, and coma. Myocardial dysfunction and arrhythmias occur rarely.
If lithium toxicity is suspected, lithium concentration should be assessed immediately and 2 hrs later to evaluate for increasing concentrations. Many preparations of lithium are sustainedrelease forms, and absorption may continue over a long period (69) . Lithium is excreted by the kidneys, so renal function must be assessed. A decreased anion gap suggests a severely elevated lithium concentration. Volume status should be assessed and isotonic saline administered as indicated. Forced diuresis is not effective in enhancing lithium excretion, but adequate urine output should be maintained. Whole bowel irrigation has been proposed as the technique of choice for GI decontamination, since lithium is not adsorbed by charcoal (8, 70) . This technique is best instituted in the ICU with close monitoring. Diuretics worsen lithium toxicity by causing salt and water depletion and increased resorption of lithium. Hemodialysis is effective in removing lithium, but controversy exists on the indications for treatment and duration of therapy (71) . Proposed indications for dialysis include renal dysfunction, severe neurologic dysfunction, inability to tolerate fluid replacement, and lithium concentration Ն4 mmol/L in acute ingestion and Ն2.5 mmol/L in chronic ingestion. The risks of hemodialysis for an individual patient must be weighed against the lithium concentration and severity of symptoms. Redistribution between intracellular and extracellular compartments can result in a rebound increase in lithium concentration 6 -8 hrs after dialysis. A lithium concentration should be assessed immediately after hemodialysis and 6 -8 hrs later. Repeat dialysis and prolonged sessions (4 -6 hrs) may be indicated if the concentration is increasing or neurologic toxicity is not improving. It is important to recognize that improvement of neurologic toxicity lags behind the decrease in serum concentration. Continuous arteriovenous and venovenous hemodiafiltration has been used to remove lithium and may be associated with less rebound, but further study is required to assess benefit (72) . Although animal studies document decreased lithium concentrations with use of sodium polystyrene sulfonate resin, the large doses are not feasible in humans and may result in hypokalemia, hypernatremia, and fluid overload. No evidence supports the use of low-dose dopamine in lithium toxicity (71) .
Opioids. Opioid toxicity produces a classic syndrome characterized by depressed level of consciousness, respiratory depression, and miosis. Additional toxicities may include hypotension, noncardiogenic pulmonary edema, aspiration pneumonitis, ileus, nausea, vomiting, and pruritis. Seizures may be associated with meperidine and propoxyphene. Heroin abuse is responsible for most fatal overdoses, especially with intravenous administration. Respiratory and hemodynamic stabilization of the patient usually is accomplished before ICU admission. Intubation and mechanical ventilation along with intravenous fluids may be necessary. Naloxone, a competitive opioid antagonist, can be administered intravenously, intramuscularly, by sublingual injection, or via endotracheal tube to reverse toxic effects. Higher doses of naloxone (10 -20 mg) may be required to reverse effects of synthetic opioids such as propoxyphene, codeine, methadone, hydrocodone, oxycodone, and fentanyl. If initial doses of naloxone restore adequate respiration and further therapy is needed, repeat boluses or a continuous infusion of naloxone can be used. The infusion dose is typically one half to two thirds of the initial amount of naloxone that reversed the respiratory depression administered on an hourly basis (73) . If the patient has been intubated, a naloxone infusion is not necessary. Nalmefene, a long-acting opioid antagonist, has been used to treat overdoses but may result in prolonged withdrawal symptoms (74) . Noncardiogenic pulmonary edema is usually self-limited (24 -36 hrs) and managed with supportive care (75) .
Organophosphates/Carbamates/Nerve Agents. Organophosphates and carbamates are acetylcholinesterase inhibitors used in insecticides. Carbamates do not enter the central nervous system, and enzyme inhibition is reversible in minutes to hours resulting in limited toxicity. Organophosphates permanently inactivate acetylcholinesterase and penetrate the central nervous system leading to greater toxicity and need for antidote administration. Nerve agents such as sarin and VX that may be used in terrorist attacks are potent organophosphates that produce cholinergic poisoning (76) . Cholinergic poisoning due to accumulation of acetylcholine at synapses exerts deleterious effects on three systems: muscarinic, nicotinic, and central nervous system (Table 3 ). The diagnosis of cholinergic poisoning is primarily clinical although low plasma acetylcholinesterase concentrations may be helpful for confirmation. The most life-threatening concerns are bronchorrhea, bronchospasm, and respiratory insufficiency (77) . The airway is best protected by early endotracheal intubation, and only nondepolarizing neuromuscular blockers should be used due to prolonged paralysis with succinylcholine (78) . After decontamination and control of the airway, the initial intervention is the intravenous administration of atropine 2-4 mg, which is repeated every 2-5 mins as needed for control of respiratory secretions. Glycopyrrolate, which does not cross the blood-brain barrier, may be considered instead of atropine if no central nervous system symptoms are present. Large doses of atropine (40 -1000 mg/day) may be needed over a prolonged period of time especially for the more lipidsoluble organophosphate insecticides. Lower doses are usually adequate for nerve agent poisoning (79) . A continuous infusion of atropine can be initiated at 0.05 mg·kg Ϫ1 ·hr Ϫ1 and titrated. After stabilization, atropine should be withdrawn slowly and respiratory secretions monitored closely.
Atropine does not reverse nicotinic effects, and pralidoxime (2-PAM) is required in patients with significant muscle weakness. Pralidoxime allows for reactivation of cholinesterases if it is given before irreversible binding of toxin occurs (usually Ͻ24 -48 hrs depending on the specific agent). The usual recommended dose is 1-2 g intravenously over 10 -20 mins followed by 200 -500 mg/hr infusion (76) . The World Health Organization-sponsored dose recommendations are a bolus of Ն30 mg/kg followed by Ͼ8 mg·kg Ϫ1 ·hr Ϫ1 infusion (80) . Delayed neurotoxicity and polyneurorapthy may occur 1-3 wks after exposure, and recovery is variable. An intermediate syndrome that occurs 24 -96 hrs after resolution of the severe cholinergic crisis also has been described (81) . In this syndrome, patients may develop respiratory paralysis, weakness, and depressed reflexes. Treatment is primarily supportive with resolution in 1-3 wks.
Salicylates. Clinical manifestations of salicylate toxicity include tinnitus, nausea/vomiting, fever, seizures, depressed level of consciousness, respiratory alkalosis, anion gap metabolic acidosis, hypoglycemia, coagulopathy, hepatic toxicity, and noncardiogenic pulmonary edema (82) . Patients with chronic rather than acute ingestions of salicylates are more likely to develop toxicity and require intensive care. A salicylate concentration should be measured initially and reassessed for continued absorption, especially with enteric-coated products. A salicylate concentration Ͼ35 mg/dL 6 hrs after acute ingestion or significant symptoms with a lower concentration should be treated with administration of sodium bicarbonate to alkalinize the urine to pH Ն7.5. Urinary alkalinization increases renal clearance of salicylate, and alkalemia promotes the movement of salicylate from brain and tissue to the blood. Hypokalemia often develops or worsens as the acidosis resolves and must be corrected (83) . The use of MDAC has been proposed but remains controversial (11) .
Volume status should be assessed and optimized because many patients have increased insensible losses. Hemodialysis may be required for concentrations Ͼ100 mg/dL in acute ingestions, seizures, persistent alteration of mental status, refractory acidosis, or persistent electrolyte abnormalities. Hemodialysis also may be necessary if patients develop fluid overload from bicarbonate therapy or they are unable to tolerate bicarbonate therapy.
Alternative Medicines. Herbal medicines and dietary supplements are the most common forms of alternative therapy in the United States and are marketed without testing for safety or efficacy. Significant toxicity may result from product misuse, contamination of the product, or interaction with other medications. Table  4 lists toxicities of some alternative medicines or agents found in some products that might require ICU care (84 -87) . Care is primarily supportive depending on the clinical manifestations. In aconitine toxicity, atropine may be considered for bradycardia or hypersalivation (88) . If cardiac glycoside toxicity is suspected, a digoxin concentration should be obtained but many glycosides are not detected in the radioimmune assay. The patient's symptoms and serum potassium concentration should be used to guide intervention. Significant toxicity should be treated with digoxin-specific antibodies (89) . After these antibodies have been administered, digoxin concentrations are no longer useful. Products also have been found to contain undeclared medications and lead, arsenic, and mercury in concentrations above limits established by the U.S. Pharmacopoeia (90) . Unusual symptoms or toxidromes in ICU patients ingesting such products may require assistance of the local health department or a toxicologist to identify a potential toxin. Additional information about specific herbs can be found at www.herbmed.org or www.mskcc.org/aboutherbs.
SUMMARY
Intensive care plays an important role in the management of patients with severe poisonings and overdoses. After resuscitation, stabilization, and initial evaluation and management, interventions Arrhythmias, gastrointestinal disturbances, visual disturbances (85) that can be used in the ICU to decrease toxin absorption or enhance elimination include whole bowel irrigation, multipledose activated charcoal, and invasive techniques such as hemodialysis and hemoperfusion. Specific interventions or antidotes may be indicated in certain poisonings, but supportive care that includes attention to airway and monitoring is also important to improve outcomes. Critical care practitioners should be familiar with the evaluation of these patients and knowledgeable about beneficial interventions.
